Catalyst Pharmaceuticals, Inc. (CPRX)

NASDAQ: CPRX · IEX Real-Time Price · USD

15.80

+0.03 (0.19%)

At close: Jul 2, 2024, 4:00 PM

15.63

-0.17 (-1.08%)

After-hours: Jul 2, 2024, 7:59 PM EDT

Catalyst Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2004
Net Income	71.41	83.08	39.48	74.98	31.88	Upgrade
Depreciation & Amortization	33.14	1.49	0.48	0.89	0.3	Upgrade
Share-Based Compensation	14.25	7.91	6.07	6.26	3.83	Upgrade
Other Operating Activities	24.8	23.58	14.33	-37.1	-1.39	Upgrade
Operating Cash Flow	143.6	116.05	60.37	45.03	34.61	Upgrade
Operating Cash Flow Growth	23.74%	92.22%	34.06%	30.11%	-	Upgrade
Capital Expenditures	-0.23	-0.03	-1.02	-0.01	-0.02	Upgrade
Acquisitions	-198.29	-10	0	0	0	Upgrade
Change in Investments	-13.47	19.24	-10	-5	37.24	Upgrade
Other Investing Activities	-81.51	-	-	-	-	Upgrade
Investing Cash Flow	-293.5	9.21	-11.02	-5.01	37.23	Upgrade
Share Issuance / Repurchase	2.79	2.66	-7.99	0.76	1.12	Upgrade
Other Financing Activities	-13.65	-0.97	-0.15	-0.06	-	Upgrade
Financing Cash Flow	-10.86	1.69	-8.14	0.7	1.12	Upgrade
Net Cash Flow	-160.76	126.95	41.21	40.73	72.95	Upgrade
Free Cash Flow	143.37	116.02	59.35	45.02	34.59	Upgrade
Free Cash Flow Growth	23.57%	95.48%	31.82%	30.15%	-	Upgrade
Free Cash Flow Margin	36.00%	54.16%	42.14%	37.81%	33.81%	Upgrade
Free Cash Flow Per Share	1.35	1.12	0.57	0.43	0.34	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).